Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1830720 | PMC |
Publication Analysis
Top Keywords
Similar Publications
Introduction: The clinical and genetic characteristics of nephrogenic diabetes insipidus (NDI) were described via assessing 2 cases of NDI patients from a Chinese family.
Patient Concerns: Two patients who manifest polyuria and polydipsia were admitted to hospital for definite diagnosis.
Diagnosis: Water deprivation-vasopressin tests showed that the patients may possess renal-origin diabetes insipidus.
Diuretics for respiratory distress syndrome in preterm infants.
Cochrane Database Syst Rev
December 2011
Neonatal-Perinatal Medicine, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Boulevard, Dallas, Texas, USA, 75390-9063.
Background: Lung edema may complicate respiratory distress syndrome (RDS) in preterm infants.
Objectives: The aim of this review was to assess the risks and benefits of diuretic administration in preterm infants with RDS.
Search Methods: The standard search method of the Cochrane Neonatal Review Group was used.
Gestational diabetes insipidus: a review of an underdiagnosed condition.
J Obstet Gynaecol Can
March 2010
Department of Obstetrics and Gynecology, University of Montreal, Montreal QC.
Objective: To review the etiology, diagnosis, and management of diabetes insipidus during pregnancy.
Data Sources: A search of the literature was performed in PubMed using key word searching and citation snowballing to identify articles published in English between January 1, 1980, and December 31, 2008, on the subject of diabetes insipidus during pregnancy. Once the articles were identified, a thorough review of all results was conducted.
Salt-losing nephrogenic diabetes insipidus caused by fetal exposure to angiotensin receptor blocker.
Pediatr Nephrol
June 2009
Department of Pediatrics, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo, Japan.
The administration of angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin type 1 receptor blockers (ARBs) to pregnant women has been reported to cause ACEI/ARB fetopathy, including oligohydramios, pulmonary hypoplasia, renal insufficiency, limb contracture, and fetal hypotension in the child. Most of the patients die or develop end-stage renal failure during the neonatal period. The long-term prognosis of renal dysfunctions of patients with ARB fetopathy has not been reported.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!